Statistical interpretation
Intention-to-treat vs per-protocol: two different trial questions
Intention-to-treat preserves randomized groups, while per-protocol focuses on participants meeting defined adherence criteria. Neither label is complete without the estimand, exclusions, missing-data assumptions, and timing of the analysis rules.
Educational content only. Not medical advice.
Intention-to-treat preserves the randomized comparison
A conventional intention-to-treat approach analyzes participants according to their randomized groups regardless of later adherence, switching, or discontinuation. This preserves the assignment created by randomization and often estimates the effect of an assignment or treatment strategy under trial conditions. It does not mean that missing outcomes can be ignored or that every post-randomization event has the same interpretation.
Per-protocol targets a more selected population
Per-protocol analyses apply predefined criteria to include participants considered sufficiently adherent to the protocol. The resulting question may be closer to effect under specified adherence, but exclusions occur after randomization and can create groups that differ for prognostic reasons. Transparent criteria, timing, participant counts, and reasons for exclusion are essential.
Modified ITT and as-treated need exact definitions
Modified intention-to-treat is not a single standard; it can exclude participants who never received an intervention, lacked a baseline measure, or had no post-baseline assessment. As-treated analysis groups people by what they received rather than what was assigned, sacrificing the original random comparison. Readers should replace labels with the actual inclusion and grouping rule.
Analysis choice should follow the estimand
The right analysis depends on the treatment effect the trial set out to estimate and how it handles intercurrent events. Presenting ITT and per-protocol results together can test robustness when both are prespecified, but agreement does not erase shared missing-data assumptions and disagreement requires explanation. A post hoc population chosen because it looks favorable is not confirmatory evidence.
Evidence limits
- The phrase intention-to-treat is applied inconsistently across published studies.
- Both approaches can be biased when outcome data are missing under unsupported assumptions.
- The appropriate estimand and sensitivity analyses depend on the trial objective.
Sources and further reading
These sources ground the definitions and evidence boundaries on this page. A citation is a route for verification, not an endorsement of a product or personal use.
U.S. Food and Drug Administration / ICH
E9(R1) Statistical Principles for Clinical Trials: Estimands and Sensitivity Analysis
Official framework connecting trial objectives, estimands, intercurrent events, analysis, and interpretation.
Open sourcePubMed Central
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials
Peer-reviewed reporting guideline for randomization, allocation, masking, participant flow, outcomes, and analysis populations.
Open sourceCochrane Handbook for Systematic Reviews of Interventions
Assessing Risk of Bias in a Randomized Trial
Authoritative methods guidance on randomization, allocation concealment, deviations, missing outcomes, measurement, and selective reporting.
Open sourceCommon questions
Does ITT include everyone randomized?
That is the ideal principle, but publications may use modified definitions; inspect the participant flow and exact analysis set.
Is per-protocol more accurate?
Not automatically. Post-randomization exclusions can introduce confounding and selection bias.
Why report both analyses?
Prespecified complementary analyses can show whether conclusions change under different, clearly stated questions and assumptions.
Continue with context
Keep building your evidence-reading skills
Explore the public PeptideSchool research library for more source-backed methods, glossaries, and evidence maps.